Zobrazeno 1 - 10
of 1 656
pro vyhledávání: '"Hirte HW"'
Autor:
Visvanath, Vinayak1 (AUTHOR), Nair, S Pradeep1 (AUTHOR) dvmchtvm@yahoo.co.in
Publikováno v:
Indian Dermatology Online Journal. Sep/Oct2024, Vol. 15 Issue 5, p870-872. 3p.
Autor:
Italiano A; Institut Bergonié, Bordeaux, France.; Gustave Roussy, Villejuif, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Miller WH Jr; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada., Blay JY; Centre Léon Bérard, Lyon, France., Gietema JA; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bang YJ; Seoul National University College of Medicine, Seoul, South Korea., Mileshkin LR; Peter MacCallum Cancer Center, Melbourne, Australia., Hirte HW; Juravinski Cancer Centre, Hamilton, ON, Canada., Higgins B; Roche Innovation Center, Hoffmann-La Roche, New York, NY, USA., Blotner S; Roche Innovation Center, Hoffmann-La Roche, New York, NY, USA., Nichols GL; Roche Innovation Center, Hoffmann-La Roche, New York, NY, USA., Chen LC; Roche Innovation Center, Hoffmann-La Roche, New York, NY, USA., Petry C; Roche Innovation Center, Basel, Switzerland., Yang QJ; Certara, Montréal, QC, Canada., Schmitt C; Roche Innovation Center, Basel, Switzerland., Jamois C; Roche Innovation Center, Basel, Switzerland., Siu LL; Princess Margaret Cancer Centre, Toronto, ON, Canada. lillian.siu@uhn.ca.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2021 Dec; Vol. 39 (6), pp. 1587-1597. Date of Electronic Publication: 2021 Jun 28.
Autor:
Durairaj C; Clinical Pharmacology, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA., Chakrabarti J; Pfizer Ltd, Surrey, UK., Ferrario C; Jewish General Hospital, McGill University, Montreal, QC, Canada., Hirte HW; Juravinski Cancer Centre, Hamilton, ON, Canada., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN, USA., Piha-Paul SA; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Plotka A; Pfizer Inc., Collegeville, PA, USA., Hoffman J; Clinical Pharmacology, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA., Shi H; Pfizer Inc., Groton, CT, USA., Wang DD; Clinical Pharmacology, Pfizer Inc., 10555 Science Center Drive, San Diego, CA, 92121, USA. Diane.Wang@Pfizer.com.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2021 Jul; Vol. 60 (7), pp. 921-930. Date of Electronic Publication: 2021 Mar 09.
Autor:
Hirte HW
Publikováno v:
OncoTargets and Therapy, Vol 2013, Iss default, Pp 427-435 (2013)
Hal W Hirte Department of Oncology, McMaster University, Hamilton, ON, Canada Abstract: The epidermal growth-factor receptor (EGFR) is overexpressed in the majority of epithelial ovarian cancers and promotes cell proliferation, migration and invasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::6fce38da35e81d906718181d424590fa
http://www.dovepress.com/profile-of-erlotinib-and-its-potential-in-the-treatment-of-advanced-ov-a12802
http://www.dovepress.com/profile-of-erlotinib-and-its-potential-in-the-treatment-of-advanced-ov-a12802
Autor:
Poznanski SM; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Singh K; Department of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada., Ritchie TM; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Aguiar JA; Department of Biology, University of Waterloo, Waterloo, ON N2L 3G1, Canada., Fan IY; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Portillo AL; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Rojas EA; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Vahedi F; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., El-Sayes A; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada., Xing S; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada., Butcher M; Juravinski Cancer Centre & McMaster University, Hamilton, ON L8V 5C2, Canada., Lu Y; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada., Doxey AC; Department of Biology, University of Waterloo, Waterloo, ON N2L 3G1, Canada., Schertzer JD; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada; Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON L8S 4K1, Canada., Hirte HW; Department of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada; Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada., Ashkar AA; Department of Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON L8N 3Z5, Canada. Electronic address: ashkara@mcmaster.ca.
Publikováno v:
Cell metabolism [Cell Metab] 2021 Jun 01; Vol. 33 (6), pp. 1205-1220.e5. Date of Electronic Publication: 2021 Apr 13.
Autor:
Su J; DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada., Bernard L; DeGroote School of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Division of Gynecologic Oncology, Juravinski Hospital & Cancer Centre, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada., Colantonio S; Department of Dermatology, University of Ottawa, Ontario, Canada., Norgaard A; Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada., Hirte HW; Division of Medical Oncology, Juravinski Hospital & Cancer Centre, Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Eiriksson L; Division of Gynecologic Oncology, Juravinski Hospital & Cancer Centre, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
Publikováno v:
Gynecologic oncology reports [Gynecol Oncol Rep] 2020 Sep 11; Vol. 34, pp. 100640. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Autor:
Dhani NC; Princess Margaret Cancer Centre, Toronto, Ontario, Canada. neesha.dhani@uhn.ca., Hirte HW; Juravinski Cancer Centre, Hamilton, Ontario, Canada., Wang L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Burnier JV; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Jain A; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Butler MO; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Welch S; London Regional Cancer Program, London, Ontario, Canada., Fleming GF; University of Chicago Medical Center, Chicago, Illinois., Hurteau J; North Shore University Health System Evanston Hospital, Evanston, Illinois., Matsuo K; University of Southern California/Norris Comprehensive Cancer Centre, Los Angeles, California., Matei D; IU Simon Cancer Center, Indianapolis, Indiana., Jimenez W; Juravinski Cancer Centre, Hamilton, Ontario, Canada., Johnston C; University of Michigan, Ann Arbor, Michigan., Cristea M; City of Hope Comprehensive Cancer Center, Duarte, California., Tonkin K; The Cross Cancer Institute, Edmonton, Alberta, Canada., Ghatage P; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Lheureux S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Mehta A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Quintos J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tan Q; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Kamel-Reid S; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Ludkovski O; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tsao MS; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Wright JJ; NCI Cancer Therapy Evaluation Program (CTEP), Bethesda, Maryland., Oza AM; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 01; Vol. 26 (11), pp. 2477-2486. Date of Electronic Publication: 2020 Jan 28.
Autor:
Oza AM; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto Canada., Matulonis UA; Dana-Farber Cancer Institute, Boston, Massachusetts., Alvarez Secord A; Duke Cancer Institute, Durham, North Carolina., Nemunaitis J; University of Toledo College of Medicine and Life Sciences, Toledo, Ohio., Roman LD; USC Norris Comprehensive Cancer Center, Los Angeles, California., Blagden SP; University of Oxford, Oxford, United Kingdom., Banerjee S; Royal Marsden NHS Foundation Trust, London, United Kingdom., McGuire WP; Virginia Commonwealth University, Richmond, Virginia., Ghamande S; Augusta University (Georgia Regents University), Augusta, Georgia., Birrer MJ; University of Alabama at Birmingham, Birmingham, Alabama., Fleming GF; The University of Chicago Medicine, Chicago, Illinois., Markham MJ; University of Florida, Gainesville, Florida., Hirte HW; Juravinski Cancer Centre, Hamilton, Canada., Provencher DM; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Canada., Basu B; Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Kristeleit R; Cancer Institute University College London, UCL, United Kingdom., Armstrong DK; Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland., Schwartz B; Northwell Health Gynecologic Oncology, Bay Shore, New York., Braly P; Women's Cancer Care, Covington, Los Angeles., Hall GD; St James University Hospital, Leeds, United Kingdom., Nephew KP; Indiana University School of Medicine, IU Simon Cancer Center, Bloomington, Indiana., Jueliger S; Astex Pharmaceuticals, Cambridge, United Kingdom., Oganesian A; Astex Pharmaceuticals Inc., Pleasanton, California., Naim S; Astex Pharmaceuticals Inc., Pleasanton, California., Hao Y; Astex Pharmaceuticals Inc., Pleasanton, California., Keer H; Astex Pharmaceuticals Inc., Pleasanton, California., Azab M; Astex Pharmaceuticals Inc., Pleasanton, California., Matei D; Northwestern University Feinberg School of Medicine, Chicago, Illinois. Daniela.matei@northwestern.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Mar 01; Vol. 26 (5), pp. 1009-1016. Date of Electronic Publication: 2019 Dec 12.
Autor:
Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A. SILVIA MISITI, 1 SIMONA NANNI, 1 GIULIA FONTEMAGGI, 1 YU-SHENG CONG, 2 JIANPING WEN, 2 HAL W. HIRTE, 3 GIULIA PIAGGIO, 1 ADA SACCHI, 1 ALFREDO PONTECORVI, 1, 4 SILVIA BACCHETTI, 2* AND ANTONELLA FARSETTI1, 5
Publikováno v:
Molecular and cellular biology (Online) 20 (2000): 3764–3771.
info:cnr-pdr/source/autori:Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A. SILVIA MISITI,1 SIMONA NANNI,1 GIULIA FONTEMAGGI,1 YU-SHENG CONG,2 JIANPING WEN,2 HAL W. HIRTE,3 GIULIA PIAGGIO,1 ADA SACCHI,1 ALFREDO PONTECORVI,1,4 SILVIA BACCHETTI,2* AND ANTONELLA FARSETTI1,5*/titolo:Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells/doi:/rivista:Molecular and cellular biology (Online)/anno:2000/pagina_da:3764/pagina_a:3771/intervallo_pagine:3764–3771/volume:20
info:cnr-pdr/source/autori:Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S, Farsetti A. SILVIA MISITI,1 SIMONA NANNI,1 GIULIA FONTEMAGGI,1 YU-SHENG CONG,2 JIANPING WEN,2 HAL W. HIRTE,3 GIULIA PIAGGIO,1 ADA SACCHI,1 ALFREDO PONTECORVI,1,4 SILVIA BACCHETTI,2* AND ANTONELLA FARSETTI1,5*/titolo:Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells/doi:/rivista:Molecular and cellular biology (Online)/anno:2000/pagina_da:3764/pagina_a:3771/intervallo_pagine:3764–3771/volume:20
In mammals, molecular mechanisms and factors involved in the tight regulation of telomerase expression and activity are still largely undefined. In this study, we provide evidence for a role of estrogens and their receptors in the transcriptional reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::68452aaaa8ca8e89e4a2571a119b0fea
http://www.cnr.it/prodotto/i/223038
http://www.cnr.it/prodotto/i/223038
Autor:
Zhou, Chao1 (AUTHOR), Yang, Yunke2 (AUTHOR), Shen, Lu2 (AUTHOR), Wang, Lu2 (AUTHOR), Zhang, Juan2 (AUTHOR), Wu, Xi2 (AUTHOR) wuxi0901@sjtu.edu.cn
Publikováno v:
BMC Cancer. 8/27/2024, Vol. 24 Issue 1, p1-10. 10p.